BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• 

  Business

  New Data Cement Lynparza’s Worth in Early Breast Cancer

  AstraZeneca and Merck announced their Lynparza drug reduced the risk of death by 32% compared to placebo for specific breast cancer patients.

  March 17, 2022

   · 

  3 min read

   · 

  Hannah Chudleigh
• 

  FDA

  COVID-19 Update: The Diabetes Connection, WHO Concerned about BA.2

  There is some evidence that COVID-19 infection might be linked to an increase in diabetes, particularly Type 1 diabetes, which is an autoimmune disease most commonly diagnosed in children.

  March 17, 2022

   · 

  8 min read

   · 

  Mark Terry
• 

  Policy

  UPDATE: Alnylam Seeks “Fair Compensation” for Lipid Technology Used in mRNA COVID-19 Vaccines

  Alnylam is suing Moderna and Pfizer over patent infringements related to its lipid techQnology that have been foundational to the success of the mRNA-based COVID-19 vaccines.

  March 17, 2022

   · 

  3 min read

   · 

  Alex Keown
• 

  Policy

  Alexion Settles Patent Infringement Lawsuits Against Ultomiris for $775M

  Alexion will pay Chugai $775 million in the second quarter of 2022 in exchange for the Japanese firm withdrawing the patent infringement lawsuits it filed in Europe, Japan and the U.S.

  March 17, 2022

   · 

  2 min read

   · 

  Vanessa Doctor, RN
• 

  Policy

  U.S. and China Edge Toward Agreement on Audits Amidst Delisting Threats

  U.S. and Chinese regulators are edging toward a cooperation plan on Chinese companies that have stock listed on U.S. stock exchanges.

  March 17, 2022

   · 

  3 min read

   · 

  Mark Terry
• 

  Business

  BioSpace Movers & Shakers: Enveda, Evaxion, Elevation

  Biopharma and life sciences companies continue to strengthen their executive teams and boards with this week’s Movers & Shakers.

  March 17, 2022

   · 

  7 min read

   · 

  Alex Keown
• 

  Drug Development

  Peginterferon Lambda Could be New Weapon Against COVID-19 Hospitalization, Deaths

  Eiger BioPharmaceuticals announced that its COVID-19 therapeutic, Peginterferon Lambda reduced the risk of hospitalization and emergency room visits by 50%.

  March 17, 2022

   · 

  3 min read

   · 

  Hayley Shasteen
• 

  Drug Development

  Intranasal COVID Vaccine Offers Hope Against Subvariants

  Codagenix is entering the vaccine arena with a possible new frontrunner in protection: CoviLiv. It’s an intranasal COVID vaccine that provides hope against subvariants.

  March 17, 2022

   · 

  3 min read

   · 

  Hayley Shasteen
• 

  Career Advice

  How to Know if Remote Work is Right for You

  Just because everyone around you seems to be switching to a work-from-home position does not mean it is the right decision for you. It’s important to weigh the options carefully before you decide.

  March 17, 2022

   · 

  5 min read

   · 

  Kaley Lefevre
• 

  Drug Development

  Roche’s Genentech Rounds Out Week of SMA Program Updates

  Genentech shared new data from its SUNFISH study evaluating the use of Evrysdi for SMA people ages 2 to 25 years diagnosed with Type 2 or Type 3 spinal muscular atrophy.

  March 17, 2022

   · 

  3 min read

   · 

  Vanessa Doctor, RN